#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Depression Ventricular fibrillation Extra-osseous Ewing's sarcoma recurrent Autoimmune hepatitis Myotonia Rhabdoid tumour Gastrointestinal stromal tumour Von Willebrand's disease Gastrointestinal neuroendocrine tumour Inflammatory myofibroblastic tumour Infertility female Osteomyelitis Keratosis follicular Rheumatoid arthritis Liposarcoma recurrent More trials…

    Learn about Rare Diseases

    Tuberous sclerosis complex – Treatment Osteosarcoma metastatic – Treatment Factor IX deficiency Carcinoid syndrome – Life with Disease Chondrosarcoma – Treatment Pelizaeus-Merzbacher disease – Basic Information Osteosarcoma recurrent – Trials in Disease Thrombotic thrombocytopenic purpura – Diagnostics Glycogen storage disease type II – Basic Information Short-bowel syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    SODIUM BENZOATE ZINC CHLORIDE IDP-121 M1P Dipotassium Salt L-Arginine Hydrochloride Allopurinol Propylene Glycol Desvenlafaxine Benzoate BI 456906 Gskvx000000008866 Amb-05X Calcium Oxybate Pabinafusp Alfa NALOXEGOL ALLERGEN EXTRACTS ANXV TORASEMIDE Topiramate TIL CELLS Clascoterone More therapies…

    Learn about Your Condition

    Menopausal symptoms Growth hormone deficiency Cutaneous lupus erythematosus Arthritis infective Intestinal infarction Bone hypertrophy Tumour of ampulla of Vater Herpes virus infection Staphylococcal infection Conjunctivitis Head and neck cancer Influenza Myxofibrosarcoma Diffuse large B-cell lymphoma Bladder cancer stage II More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Satakunnan hyvinvointialue

Satakunnan hyvinvointialue

Sairaalantie 3 Pori Satakunta, Pori, 28500, Finland

Want to learn more about this study or check if you can participate? Contact us.

  • Evaluating the effect of recombinant varicella zoster virus glycoprotein E on the risk of dementia in adults aged 76 years and older

    Recruiting

    3 1 1
    Investigated Drugs:
    • Recombinant Varicella Zoster Virus Glycoprotein E
    Finland
  • Study on the Effects of Fluorouracil and Capecitabine in Patients with Metastatic Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    • Colorectal cancer
    Investigated Drugs:
    • Capecitabine
    • Fluorouracil
    Finland
  • Study on Long-Term Safety of Enzalutamide, Abiraterone, and Prednisolone for Patients with Prostate Cancer from Previous Enzalutamide Trials

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Abiraterone
    • Enzalutamide
    • Prednisolone
    Austria Belgium Czechia Denmark Finland France +9
  • Study on Enzalutamide and Leuprorelin Acetate for Men with High-Risk Nonmetastatic Prostate Cancer After Treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Leuprorelin Acetate
    • Enzalutamide
    Austria Denmark Finland France Italy The Netherlands +4

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!